“Improving Prognosis of Canine Cutaneous Mast Cell Tumors with Immunohistochemical Detection of KIT, Ki67, and Bax or Alternative Grading Systems and Mitotic Count”

https://pubmed.ncbi.nlm.nih.gov/38112689

Canine cutaneous mast cell tumors’ prognosis can be improved with immunohistochemical detection of KIT, Ki67, and Bax, and if unavailable, mitotic count and values from both grading systems provide the most reliable data.